← Back to All Filings

ORGO Insider & 10% Owner Buys $1.1M Stock, Disgorges Profit

Medium SignificanceNovember 3, 2025 at 5:32:35 PM EST

Organogenesis Holdings Inc.

$ORGO4CIK: 0001661181

Subscribe to track ORGO

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ORGO Insider & 10% Owner Buys $1.1M Stock

Company: Organogenesis Holdings Inc. (ORGO) Form: 4 | Filed: 2025-11-03 Significance: Medium

Insider: NUSSDORF GLENN H Title: n/a | Relationship: Director, 10% Owner

Transaction (Net): • Type: Net Purchase • Shares: 335,719 (net acquired) • Value: ~$1.02M • Owned After: 12,248,560 shares (9.66% of company)

Key Insight: A key insider made significant net purchases totaling over $1M. Subsequent smaller sales were explicitly to disgorge short-swing profits back to the company, a corrective action rather than a change in sentiment.

Market Context: The purchases represent a notable vote of confidence from a major insider, increasing their already substantial stake in the $540M market cap company.

Comprehensive Analysis

SEC Filing Analysis: Organogenesis Holdings Inc. (ORGO)

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: A Director and 10% Owner, Glenn H. Nussdorf, executed net purchases of Organogenesis stock worth over $1 million, signaling strong insider confidence. Subsequent sales were corrective actions to disgorge short-swing profits as noted in the filing.
  • Market Impact: The net positive investment from a major insider is a bullish signal, though the complexity of the short-swing profit disgorgement makes the overall market reaction likely neutral to moderately positive.

Company Information

FieldValue
CompanyOrganogenesis Holdings Inc.
Ticker SymbolORGO
CIK0001661181
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameNUSSDORF GLENN H
CIK0001244191
Title/Positionnull
RelationshipDirector, 10% Owner

Transaction Details

This filing reported a series of transactions, resulting in a net acquisition of shares.

DateCodeTypeSharesPriceValue
2025-05-14PPurchase251,001$3.0878$775,050
2025-05-15PPurchase107,494$2.9862$321,014
2025-06-09SSale4,156$3.5003$14,547
2025-06-10SSale18,620$3.5583$66,256
  • Net Shares Acquired: 335,719
  • Net Investment: $1,015,261
  • Final Shares Owned (Total): 12,248,560
  • Ownership Type: Direct & Indirect

Financial Impact Assessment

Transaction Materiality (Based on Net Activity)

MetricValue
Net Transaction Value$1,015,261
% of Market Cap0.19%
Net Shares Transacted335,719
% of Shares Outstanding0.26%
Post-Transaction Ownership12,248,560 shares (9.66% of outstanding)
Materiality AssessmentSignificant

Impact Evaluation

  • Market Cap Context: For Organogenesis, with a market cap of $540 million, a net insider investment of over $1 million is a significant event. It represents a meaningful capital allocation by the insider.
  • Ownership Concentration: The insider's post-transaction stake of 9.66% represents a very high level of ownership concentration, strongly aligning their financial interests with those of other shareholders.
  • Transaction Significance: The transaction represents 0.26% of total shares outstanding. While not exceeding the 0.5% threshold for 'Highly Significant', the dollar value, insider's dual role as Director and 10% Owner, and the context of the trades elevate its importance to 'Significant'.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The large net purchase is a fundamentally positive signal. However, the subsequent sales, even though for disgorging short-swing profits, introduce complexity. This suggests a potential trading error, which may temper the market's positive interpretation.

Volume & Sentiment

  • Expected Volume Impact: A potential short-term increase in trading volume as the market digests the news of a large insider purchase.
  • Sentiment Indicator: Neutral to slightly Bullish. The core signal is the $1M+ net investment, which is bullish. The corrective sale is a neutral technical event.

Investment Insights

Positive Market Indicators

  • A Director and 10% Owner has committed over $1 million in new capital, signaling strong conviction in the company's prospects.
  • The insider maintains a substantial ownership stake of nearly 10%, indicating a long-term alignment with shareholder value creation.

Risk Factors

  • The occurrence of a short-swing profit transaction requiring disgorgement, while corrected, could be perceived as a minor governance misstep or lack of procedural oversight on the part of the insider's trading plan.

Key Takeaways

  1. Strong Insider Conviction: The primary signal is a significant net purchase by a key insider.
  2. High Ownership: The insider is one of the largest shareholders, making their actions particularly noteworthy.
  3. Short-Swing Profit Context: The sales reported are not indicative of a bearish outlook but are a technical requirement to return profits from a trade made within a six-month window, as detailed in Footnote 5.

Additional Context

Special Circumstances

  • According to Footnote 5, the sales on June 9 and June 10 were matched against the May 15 purchase under Section 16(b) of the Securities Exchange Act. The insider paid the company $13,285.24, representing the full profit plus interest from this 'short-swing' transaction. This is a crucial detail that frames the sales as a corrective measure, not a change in investment thesis.
Topics:#SECFiling#InsiderTrading#ORGO#Organogenesis#Form4#InsiderBuy#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.